James Gruber
Director of Finance/CFO at ETON PHARMACEUTICALS, INC.
Net worth: 13 496 $ as of 2024-03-30
James Gruber active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ETON PHARMACEUTICALS, INC. | Director of Finance/CFO | 2022-04-10 | - |
| Corporate Secretary | 2022-04-10 | - | |
| Treasurer | 2022-04-10 | - |
Career history of James Gruber
Former positions of James Gruber
| Companies | Position | Start | End |
|---|---|---|---|
Horizon Therapeutics, Inc.
 Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance. | Comptroller/Controller/Auditor | - | - |
Training of James Gruber
| Indiana University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistics
International
| United States | 4 |
| 2 |
Operational
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
| Treasurer | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Horizon Therapeutics, Inc.
Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance. | Health Technology |
| Eton Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- James Gruber
- Experience